Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biogen Idec reports baminercept data

BIIB said interim data showed that baminercept (LTBR-Fc) plus methotrexate improved

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE